Evaluating Microbiome Therapies with Intestinal Cell Models

Scott Magness, Ph.D., Chief Science Officer and Co-Founder of Altis Biosystems explains how the company's intestinal tissue models can facilitate preclinical studies of therapies targeting the microbiome.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.